» Authors » Jorge A Wong

Jorge A Wong

Explore the profile of Jorge A Wong including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 57
Citations 1405
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Wong J, Conen D, Healey J, Johnson L
Open Heart . 2022 May; 7(1). PMID: 35594162
Objective: Heart failure (HF) frequently complicates atrial fibrillation (AF) and significantly increases mortality risk. Limited data exist on the modifiable risk factors associated with development of HF in AF patients....
12.
Oraii A, Healey J, Benz A, Pandey A, Wong J, Fonguh S, et al.
Can J Cardiol . 2022 May; 38(9):1434-1441. PMID: 35562018
Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) reduce heart failure (HF) in a broad range of populations, but they have not been studied specifically in patients with atrial fibrillation (AF). We...
13.
Goodliffe L, Ainsworth C, Whitlock R, Chan N, Wong J, Rivard G, et al.
Can J Cardiol . 2022 Apr; 38(9):1464-1466. PMID: 35436534
No abstract available.
14.
Wong J
Heart . 2022 Mar; 108(9):664-665. PMID: 35228267
No abstract available.
15.
Capucci A, Wong J, Gold M, Boehmer J, Ahmed R, Kwan B, et al.
JACC Clin Electrophysiol . 2022 Feb; 8(2):182-193. PMID: 35210075
Objectives: This study sought to investigate the temporal association between changes in physiologic heart failure (HF) sensors, atrial fibrillation (AF) progression, and clinical HF in patients with cardiac resynchronization therapy...
16.
McIntyre W, Wang J, Benz A, Johnson L, Connolly S, Van Gelder I, et al.
Europace . 2022 Jan; 24(7):1058-1064. PMID: 35061877
Aims: There is uncertainty about whether and how to perform screening for atrial fibrillation (AF). To estimate the incidence of previously undetected AF that would be captured using a continuous...
17.
Krisai P, Johnson L, Moschovitis G, Benz A, Ramasundarahettige C, McIntyre W, et al.
CJC Open . 2022 Jan; 3(12):1482-1489. PMID: 34993460
Background: Heart failure (HF) is a frequent cause of hospitalization and death in patients with atrial fibrillation (AF). Identifying AF patients at risk of HF hospitalization could help select individuals...
18.
Lurie A, Wang J, Healey J, Wong J
J Am Coll Cardiol . 2021 Sep; 78(13):e91-e92. PMID: 34556328
No abstract available.
19.
Johnson L, Oldgren J, Barrett T, McNaughton C, Wong J, McIntyre W, et al.
J Am Heart Assoc . 2021 Sep; 10(18):e017735. PMID: 34514842
Background Heart failure (HF) is a common complication to atrial fibrillation (AF), leading to rehospitalization and death. Early identification of patients with AF at risk for HF might improve outcomes....
20.
Pandey A, Okaj I, Kaur H, Belley-Cote E, Wang J, Oraii A, et al.
J Am Heart Assoc . 2021 Aug; 10(17):e022222. PMID: 34459238
Background Sodium-glucose co-transporter (SGLT) inhibitors reduce cardiovascular outcomes including mortality in several populations; however, their effect on atrial fibrillation/flutter (AF) remains unclear. Our objective was to determine whether SGLT inhibitors...